Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,552.93
(
-0.81%
)
US TECH 100
23,438.00
(
-1.19%
)
Dow Jones
45,811.01
(
-0.46%
)
Brent Oil
106.27
(
1.76%
)
Bitcoin
70,165.00
(
0.38%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 103879

Friday, 09/10/2010 5:57:22 PM

Friday, September 10, 2010 5:57:22 PM

Post# of 257262
Court rules APP Pharma lacks standing to appeal ruling in the Angiomax patent suit between MDCO and the USPTO, which was decided in MDCO’s favor:

http://finance.yahoo.com/news/The-Medicines-Company-iw-678514381.html?x=0&.v=1

Touch luck for APP Phrama, which had hoped to launch a generic version of Angiomax and will now have to wait until the expiration of the extended patent.

(Note: APP Pharma has nothing to do with APPA.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today